Marshall Wace, LLP Gossamer Bio, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 3,484,932 shares of GOSS stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,484,932
Previous 3,335,511 4.48%
Holding current value
$2.93 Million
Previous $3 Million 14.96%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.79 - $1.25 $118,042 - $186,776
149,421 Added 4.48%
3,484,932 $3.45 Million
Q2 2024

Aug 14, 2024
BUY
$0.51 - $1.27 $1.07 Million - $2.67 Million
2,103,766 Added 170.8%
3,335,511 $3 Million
Q1 2024

May 15, 2024
BUY
$0.8 - $1.51 $172,769 - $326,102
215,962 Added 21.26%
1,231,745 $1.45 Million
Q4 2023

Feb 14, 2024
SELL
$0.48 - $1.08 $302,895 - $681,514
-631,032 Reduced 38.32%
1,015,783 $924,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $81,354 - $189,826
-104,300 Reduced 5.96%
1,646,815 $1.37 Million
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $18,912 - $29,525
-19,298 Reduced 1.09%
1,751,115 $2.1 Million
Q1 2023

May 15, 2023
BUY
$0.96 - $2.92 $724,764 - $2.2 Million
754,963 Added 74.35%
1,770,413 $2.23 Million
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $897,655 - $6.64 Million
515,894 Added 103.27%
1,015,450 $2.2 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $1.09 Million - $2.26 Million
151,805 Added 43.65%
499,556 $5.99 Million
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $1.34 Million - $2.24 Million
-224,321 Reduced 39.21%
347,751 $2.91 Million
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $5.59 Million - $7.78 Million
552,820 Added 2871.49%
572,072 $6.47 Million
Q1 2021

May 17, 2021
SELL
$8.63 - $10.94 $107,219 - $135,918
-12,424 Reduced 39.22%
19,252 $178,000
Q4 2020

Feb 16, 2021
SELL
$8.3 - $13.59 $55,468 - $90,821
-6,683 Reduced 17.42%
31,676 $306,000
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $433,456 - $565,795
38,359 New
38,359 $476,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $78.9M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email